1-20 of 30
Gunhild M. Mælandsmo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4675: Chemoresistant patient-derived xenografts to identify treatment options in breast cancer patients not responding to standard chemotherapy

Eivind Valen Egeland, Kotryna Seip, Geir Frode Øy, Eleni Skourti, Solveig J Pettersen, Siri Juell, Mads Haugland Haugen, Olav Engebraaten, Lina Prasmickaite, Gunhild M Maelandsmo
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4675.
https://doi.org/10.1158/1538-7445.AM2023-4675
Published: 04 April 2023
View article titled, Abstract 4675: Chemoresistant patient-derived xenografts to identify treatment options in breast cancer patients not responding to standard chemotherapy
Journal Articles

Abstract 5627: Spatial protein profiling by cyclic immunofluorescence to interpret and improve bulk tumor-based predictor of response to chemotherapy with bevacizumab in neoadjuvant breast cancer treatment

Mads Haugland Haugen, David Kilburn, Hongli Ma, Cameron Watson, Allison Creason, Dong Zhang, Maria Aa Dahle, Ole Christian Lingjaerde, Marianne L. Smebye, Oeystein Garred, Mette S. Foersund, Mai T. Nguyen, Gunhild M. Maelandsmo, Gordon Mills, Olav Engebraaten
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5627.
https://doi.org/10.1158/1538-7445.AM2023-5627
Published: 04 April 2023
View article titled, Abstract 5627: Spatial protein profiling by cyclic immunofluorescence to interpret and improve bulk tumor-based predictor of response to chemotherapy with bevacizumab in neoadjuvant breast cancer treatment
Journal Articles

Abstract 3128: Immune microenvironment of colorectal tumors and matched liver metastases

Vegar J. Dagenborg, Serena Elizabeth Marshall, Krzysztof Grzyb, Åsmund A. Fretland, Marius Lund-Iversen, Gunhild M. Mælandsmo, Anne-Lise Børresen-Dale, Anne H. Ree, Bjørn Edwin, Sheraz Yaqub, Kjersti Flatmark
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3128.
https://doi.org/10.1158/1538-7445.AM2018-3128
Published: 01 July 2018
View article titled, Abstract 3128: Immune microenvironment of colorectal tumors and matched liver metastases
Journal Articles

Abstract 4705: The novel oncolytic peptide, DTT-304, induces regression of colorectal cancer tumors in vivo

Karianne G. Fleten, Johannes J. Eksteen, Brynjar Mauseth, Ketil Camilio, Øystein Rekdal, Meng Yu Wang, Gunhild M. Mælandsmo, Kjersti Flatmark
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4705.
https://doi.org/10.1158/1538-7445.AM2018-4705
Published: 01 July 2018
View article titled, Abstract 4705: The novel oncolytic peptide, DTT-304, induces regression of colorectal cancer tumors in vivo
Journal Articles

Abstract 4412: Metabolic reprogramming in EMT - targeting regulatory nodes in mesenchymal cells

Bylgja Hilmarsdottir, Skarphedinn Halldorsson, Maria T. Grinde, Anna Barkovskaya, Solveig Pettersen, Thorarinn Gudjonsson, Siver A. Moestue, Ottar Rolfsson, Gunhild M. Mælandsmo
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4412.
https://doi.org/10.1158/1538-7445.AM2017-4412
Published: 01 July 2017
View article titled, Abstract 4412: Metabolic reprogramming in EMT - targeting regulatory nodes in mesenchymal cells
Journal Articles

Abstract 1131: O-GlcNAc transferase inhibition in breast cancer cells

Anna Barkovskaya, Lina Prasmickaite, Damien Y. Duveau, Ian G. Mills, Gunhild M. Mælandsmo, Siver A. Moestue, Harri M. Itkonen
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1131.
https://doi.org/10.1158/1538-7445.AM2017-1131
Published: 01 July 2017
View article titled, Abstract 1131: O-GlcNAc transferase inhibition in breast cancer cells
Journal Articles

Abstract 1813: Bevacizumab potentiates the proteomic response to neoadjuvant chemotherapy in breast cancer patients: Rppa exploration of consecutive tumor samples in the NeoAva randomized phase II trial

Mads H. Haugen, Ole Christian Lingjaerde, Marit Krohn, Wei Zhao, Evita M. Lindholm, Laxmi Silwal-Pandit, Elin Borgen, Øystein Garred, Anne Fangberget, Marit M. Holmen, Ellen Schlichting, Helle K. Skjerven, Steinar Lundgren, Erik Wist, Bjørn Naume, Gunhild M. Maelandsmo, Yiling Lu, Anne-Lise Boerresen-Dale, Gordon B. Mills, Olav Engebraaten
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1813.
https://doi.org/10.1158/1538-7445.AM2017-1813
Published: 01 July 2017
View article titled, Abstract 1813: Bevacizumab potentiates the proteomic response to neoadjuvant chemotherapy in breast cancer patients: Rppa exploration of consecutive tumor samples in the NeoAva randomized phase II trial
Journal Articles

Abstract 1752: Immune-related gene signatures in colorectal liver metastases: Exposing an opportunity for immune modulating therapy

Vigdis Nygaard, Vegar J. Dagenborg, Olga Østrup, Einar A. Rødland, Veronica Skarpeteig, Laxmi Silwal-Pandit, Krzysztof Grzyb, Audun E. Berstad, Åsmund A. Fretland, Gunhild M. Mælandsmo, Anne-Lise Børresen-Dale, Anne H. Ree, Bjørn Edwin, Kjersti Flatmark
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1752.
https://doi.org/10.1158/1538-7445.AM2017-1752
Published: 01 July 2017
View article titled, Abstract 1752: Immune-related gene signatures in colorectal liver metastases: Exposing an opportunity for immune modulating therapy
Journal Articles

Abstract 1660: Humanization of patient derived xenograft (PDX) cancer model mice with peripheral blood mononuclear cells (PBMCs)

Jens Henrik Norum, Dag Josefsen, Gunnar Kvalheim, Olav Engebråten, Therese Sørlie, Gunhild M. Mælandsmo
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1660.
https://doi.org/10.1158/1538-7445.AM2017-1660
Published: 01 July 2017
View article titled, Abstract 1660: Humanization of patient derived xenograft (PDX) cancer model mice with peripheral blood mononuclear cells (PBMCs)
Journal Articles

Abstract 4329: Targetable nodes in fibroblast-supported melanoma cells that show resistance to BRAF inhibitors

Kotryna Seip, Marco V. Haselager, Kjetil Jørgensen, Marco Albrecht, Mads H. Haugen, Eivind Valen Egeland, Philippe Lucarelli, Thomas Sauter, Olav Engebraaten, Gunhild M. Mælandsmo, Lina Prasmickaite
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4329.
https://doi.org/10.1158/1538-7445.AM2017-4329
Published: 01 July 2017
View article titled, Abstract 4329: Targetable nodes in fibroblast-supported melanoma cells that show resistance to BRAF inhibitors
Journal Articles

Abstract 4218: Diffusion-weighted MRI can predict response to aflibercept in in vivo models

Karianne G. Fleten, Kine M. Bakke, Andreas Abildgaard, Gunhild M. Mælandsmo, Katrine Røe Redalen, Kjersti Flatmark
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4218.
https://doi.org/10.1158/1538-7445.AM2016-4218
Published: 15 July 2016
View article titled, Abstract 4218: Diffusion-weighted MRI can predict response to aflibercept in <em>in vivo</em> models
Journal Articles

Abstract 3737: Inhibition of O-GlcNAc transferase in tamoxifen resistant breast cancer cells

Anna Barkovskaya, Lina Prasmickaite, Ian G. Mills, Gunhild M. Mælandsmo, Siver A. Moestue, Harri M. Itkonen
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3737.
https://doi.org/10.1158/1538-7445.AM2016-3737
Published: 15 July 2016
View article titled, Abstract 3737: Inhibition of O-GlcNAc transferase in tamoxifen resistant breast cancer cells
Journal Articles

Abstract 3268: Proteomic response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Reverse phase protein array (RPPA) results from NeoAva - a randomized phase II study

Mads H. Haugen, Ole Christian Lingjaerde, Marit Krohn, Evita M. Lindholm, Laxmi Silwal-Pandit, Elin Borgen, Øystein Garred, Anne Fangberget, Marit M. Holmen, Ellen Schlichting, Helle Skjerven, Steinar Lundgren, Erik Wist, Bjoern Naume, Gunhild M. Maelandsmo, Yiling Lu, Anne-Lise Boerresen-Dale, Gordon B. Mills, Olav Engebraaten
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3268.
https://doi.org/10.1158/1538-7445.AM2016-3268
Published: 15 July 2016
View article titled, Abstract 3268: Proteomic response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Reverse phase protein array (RPPA) results from NeoAva - a randomized phase II study
Journal Articles

Abstract 1093: Legumain in colorectal cancer: Unorthodox localization and trafficking

Mads H. Haugen, Kjersti Flatmark, Ingrid Damgaard, Tripti Tamhane, Birgit Engesæter, Siri Tveito, Eivind V. Egeland, Rigmor Solberg, Harald T. Johansen, Solveig J. Pettersen, Kjetil Boye, Klaudia Brix, Gunhild M. Mælandsmo
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1093.
https://doi.org/10.1158/1538-7445.AM2014-1093
Published: 01 October 2014
View article titled, Abstract 1093: Legumain in colorectal cancer: Unorthodox localization and trafficking
Journal Articles

Abstract 2004: S100A4 in colorectal cancer - biological function of nuclear localization

Eivind V. Egeland, Kjetil Boye, Kjersti Flatmark, Solveig J. Pettersen, Tove Oyjord, Gunhild M. Maelandsmo
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2004.
https://doi.org/10.1158/1538-7445.AM2014-2004
Published: 01 October 2014
View article titled, Abstract 2004: S100A4 in colorectal cancer - biological function of nuclear localization
Journal Articles

Abstract A50: KRAS mutational status and expressions of p53 and S100A4 proteins in pancreatic adenocarcinomas.

Inger Marie Bowitz Lothe, Tone Ikdahl, Trond Buanes, Knut Jørgen Labori, Ole Petter Clausen, Gunhild M. Mælandsmo, Kjetil Boye, Tor Jacob Eide, Elin Kure
Journal: Cancer Research
Cancer Res (2012) 72 (14_Supplement): A50.
https://doi.org/10.1158/1538-7445.PANCA2012-A50
Published: 03 April 2014
View article titled, Abstract A50: KRAS mutational status and expressions of p53 and S100A4 proteins in pancreatic adenocarcinomas.
Journal Articles

Abstract LB-299: Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in luminal and basal-like breast cancer xenografts

Evita Lindholm, Alexandr Kristian, Hawa Nalvoga, Kristi Kruger, Gunhild M. Mælandsmo, Lars A. Akslen, Olav Engebraaten
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-299.
https://doi.org/10.1158/1538-7445.AM2011-LB-299
Published: 15 April 2011
View article titled, Abstract LB-299: Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in luminal and basal-like breast cancer xenografts
Journal Articles

STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate Cancer

Ling Wang, Yang Jin, Yke Jildouw Arnoldussen, Ida Jonson, Su Qu, Gunhild M. Mælandsmo, Alexandr Kristian, Bjørn Risberg, Håkon Wæhre, Håvard E. Danielsen, Fahri Saatcioglu
Journal: Cancer Research
Cancer Res (2010) 70 (14): 5818–5828.
https://doi.org/10.1158/0008-5472.CAN-09-4697
Published: 14 July 2010
View article titled, STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate Cancer
Open the PDF for STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract LB-73: Nuclear S100A4 is a novel prognostic marker in colorectal cancer

Kjetil Boye, Jahn M. Nesland, Berit Sandstad, Gunhild M. Mælandsmo, Kjersti Flatmark
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-73.
https://doi.org/10.1158/1538-7445.AM10-LB-73
Published: 15 April 2010
View article titled, Abstract LB-73: Nuclear S100A4 is a novel prognostic marker in colorectal cancer
Journal Articles

Abstract 4304: Malignant melanoma cells with aggressive properties are common and not distinguishable by proposed markers for cancer stem cells

Lina Prasmickaite, Birgit Engesæter, Nirma Skrbo, Nina K. Oliver, Olav Engebråten, Zhenhe Suo, Steinar Aamdal, Øystein Fodstad, Gunhild M. Mælandsmo
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4304.
https://doi.org/10.1158/1538-7445.AM10-4304
Published: 15 April 2010
View article titled, Abstract 4304: Malignant melanoma cells with aggressive properties are common and not distinguishable by proposed markers for cancer stem cells